Resumen de acción YPSN
Ypsomed Holding AG, junto con sus filiales, desarrolla, fabrica y vende sistemas de inyección e infusión para empresas farmacéuticas y biotecnológicas. Saber más
| Puntuación del snowflake | |
|---|---|
| Valoración | 2/6 |
| Crecimiento futuro | 4/6 |
| Rendimiento pasado | 3/6 |
| Salud financiera | 3/6 |
| Dividendos | 0/6 |
Competidores de Ypsomed Holding AG
Historial de precios y rendimiento
| Precios históricos de las acciones | |
|---|---|
| Precio actual de la acción | CHF 357.00 |
| Máximo en las últimas 52 semanas | CHF 439.00 |
| Mínimo de 52 semanas | CHF 287.50 |
| Beta | 0.97 |
| 1Cambio en 1 mes | -11.96% |
| Variación en 3 meses | -7.63% |
| Cambio de 1 año | 18.21% |
| 3Variación en 3 años | 105.88% |
| Variación en 5 años | 163.27% |
| Variación desde la OPV | 382.43% |
Noticias y actualizaciones recientes
We Think That There Are Some Issues For Ypsomed Holding (VTX:YPSN) Beyond Its Promising Earnings
Nov 20
Here's What Analysts Are Forecasting For Ypsomed Holding AG (VTX:YPSN) After Its Interim Results
Nov 17Recent updates
We Think That There Are Some Issues For Ypsomed Holding (VTX:YPSN) Beyond Its Promising Earnings
Nov 20Here's What Analysts Are Forecasting For Ypsomed Holding AG (VTX:YPSN) After Its Interim Results
Nov 17Investors Appear Satisfied With Ypsomed Holding AG's (VTX:YPSN) Prospects
Aug 13There Are Reasons To Feel Uneasy About Ypsomed Holding's (VTX:YPSN) Returns On Capital
Jul 31If EPS Growth Is Important To You, Ypsomed Holding (VTX:YPSN) Presents An Opportunity
Jul 03Here's Why Ypsomed Holding AG's (VTX:YPSN) CEO May Deserve A Raise
Jun 19Should You Investigate Ypsomed Holding AG (VTX:YPSN) At CHF395?
Jun 10Here's What Analysts Are Forecasting For Ypsomed Holding AG (VTX:YPSN) After Its Full-Year Results
May 25Investors Appear Satisfied With Ypsomed Holding AG's (VTX:YPSN) Prospects
May 08Investors Could Be Concerned With Ypsomed Holding's (VTX:YPSN) Returns On Capital
Apr 07Is There Now An Opportunity In Ypsomed Holding AG (VTX:YPSN)?
Mar 09Here's Why We Think Ypsomed Holding (VTX:YPSN) Might Deserve Your Attention Today
Feb 07We Think Ypsomed Holding (VTX:YPSN) Can Stay On Top Of Its Debt
Jan 23Ypsomed Holding AG's (VTX:YPSN) Popularity With Investors Is Clear
Jan 08Here's What's Concerning About Ypsomed Holding's (VTX:YPSN) Returns On Capital
Dec 23Should You Investigate Ypsomed Holding AG (VTX:YPSN) At CHF298?
Dec 05Do Ypsomed Holding's (VTX:YPSN) Earnings Warrant Your Attention?
Sep 28Ypsomed Holding (VTX:YPSN) Seems To Use Debt Quite Sensibly
Sep 10Ypsomed Holding (VTX:YPSN) May Have Issues Allocating Its Capital
Aug 23Should You Think About Buying Ypsomed Holding AG (VTX:YPSN) Now?
Aug 08Should You Be Adding Ypsomed Holding (VTX:YPSN) To Your Watchlist Today?
Jun 13Ypsomed Holding (VTX:YPSN) Seems To Use Debt Quite Sensibly
May 28What Does Ypsomed Holding AG's (VTX:YPSN) Share Price Indicate?
May 06Ypsomed Holding (VTX:YPSN) Could Be Struggling To Allocate Capital
Apr 21At CHF187, Is It Time To Put Ypsomed Holding AG (VTX:YPSN) On Your Watch List?
Feb 01These 4 Measures Indicate That Ypsomed Holding (VTX:YPSN) Is Using Debt Reasonably Well
Jan 17Is Now The Time To Put Ypsomed Holding (VTX:YPSN) On Your Watchlist?
Dec 27Investors Shouldn't Be Too Comfortable With Ypsomed Holding's (VTX:YPSN) Robust Earnings
Nov 24What Is Ypsomed Holding AG's (VTX:YPSN) Share Price Doing?
Oct 19Why Ypsomed Holding AG (VTX:YPSN) Could Be Worth Watching
Jul 14Here's What's Concerning About Ypsomed Holding's (VTX:YPSN) Returns On Capital
Jun 20Should You Investigate Ypsomed Holding AG (VTX:YPSN) At CHF161?
Feb 28Rentabilidad de los accionistas
| YPSN | CH Medical Equipment | Mercado CH | |
|---|---|---|---|
| 7D | -0.3% | -0.1% | 0.6% |
| 1Y | 18.2% | 10.1% | 6.4% |
Rentabilidad vs. Industria: YPSN superó a la industria Swiss Medical Equipment, que obtuvo un rendimiento del 10.1% el año pasado.
Rentabilidad vs. Mercado: YPSN superó al mercado Swiss, que obtuvo un rendimiento del 6.4% el año pasado.
Volatilidad de los precios
| YPSN volatility | |
|---|---|
| YPSN Average Weekly Movement | 4.7% |
| Medical Equipment Industry Average Movement | 4.0% |
| Market Average Movement | 3.3% |
| 10% most volatile stocks in CH Market | 6.6% |
| 10% least volatile stocks in CH Market | 1.6% |
Precio estable de las acciones: El precio de las acciones de YPSN ha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de YPSN(5%) se ha mantenido estable durante el último año, pero sigue siendo superior al 75% de las acciones de Swiss.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1984 | 2,600 | Simon Michel | www.ypsomed.com |
Ypsomed Holding AG, junto con sus filiales, desarrolla, fabrica y vende sistemas de inyección e infusión para empresas farmacéuticas y biotecnológicas. La empresa opera a través de dos segmentos, Ypsomed Delivery Systems e Ypsomed Diabetes Care. El segmento Ypsomed Delivery Systems suministra diversos sistemas de inyección, como inyectores-bolígrafo, autoinyectores e inyectores portátiles, así como otros dispositivos inteligentes.
Resumen de fundamentos de Ypsomed Holding AG
| Estadísticas fundamentales de YPSN | |
|---|---|
| Capitalización bursátil | CHF 4.87b |
| Beneficios(TTM) | CHF 74.39m |
| Ingresos (TTM) | CHF 617.07m |
65.5x
Ratio precio-beneficio (PE)7.9x
Ratio precio-ventas (PS)¿Está YPSN sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de YPSN | |
|---|---|
| Ingresos | CHF 617.07m |
| Coste de los ingresos | CHF 398.41m |
| Beneficio bruto | CHF 218.66m |
| Otros gastos | CHF 144.28m |
| Beneficios | CHF 74.39m |
Últimos beneficios comunicados
Sep 30, 2024
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 5.45 |
| Margen bruto | 35.44% |
| Margen de beneficio neto | 12.05% |
| Ratio deuda/patrimonio | 52.3% |
¿Cómo se ha desempeñado YPSN a largo plazo?
Ver rendimiento histórico y comparativa